Histopathologic Findings of Multifocal Pancreatic Intraductal Papillary Mucinous Neoplasms on CT

Size: px
Start display at page:

Download "Histopathologic Findings of Multifocal Pancreatic Intraductal Papillary Mucinous Neoplasms on CT"

Transcription

1 Gastrointestinal Imaging Original Research Raman et al. CT of Multifocal Pancreatic IPMNs Gastrointestinal Imaging Original Research Siva P. Raman 1 Satomi Kawamoto 1 Amanda Blackford 2 Ralph H. Hruban 3 Anne Marie O Brien-Lennon 4 Christopher L. Wolfgang 5 Neda Rezaee 5 Barish Edil 5 Elliot K. Fishman 1 Raman SP, Kawamoto S, Blackford A, et al. Keywords: CT, intraductal papillary mucinous neoplasms, pancreas DOI: /AJR Received March 16, 2012; accepted after revision August 22, Department of Radiology, Johns Hopkins University, 601 N Caroline St, JHOC 3251, Baltimore, MD Address correspondence to S. P. Raman (srsraman3@gmail.com). 2 Department of Oncology Biostatistics, Johns Hopkins School of Medicine, Baltimore, MD. 3 Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, MD. 4 Department of Gastroenterology, Johns Hopkins University, Baltimore, MD. 5 Department of Surgery, Johns Hopkins University, Baltimore, MD. AJR 2013; 200: X/13/ American Roentgen Ray Society Histopathologic Findings of Multifocal Pancreatic Intraductal Papillary Mucinous Neoplasms on CT OBJECTIVE. The criteria for resection of solitary pancreatic side-branch intraductal papillary mucinous neoplasm (IPMN) have been well described by the Sendai consensus statement. However, the management of multiple pancreatic cystic lesions is less certain, with no clear guidelines in the literature to date. The purpose of this study was to evaluate the histopathologic findings in pancreatic IPMNs in patients with multiple ( 4) pancreatic cysts. MATERIALS AND METHODS. The CT scans of all patients with a pathologically proven IPMN at our institution were reviewed, and a total of 52 patients with four or more pancreatic cysts were found. Each case was reviewed for the number of cysts and the presence of signs of invasive malignancy including a coexistent solid pancreatic mass, pancreatic ductal dilatation, and mural nodularity. RESULTS. A total of 52 patients (19 men, 33 women; mean age, 71.8 years) were found to have multifocal IPMNs, defined as four or more cysts, on CT. Of these 52 patients, nine also had evidence of a solid pancreatic mass on CT. Retrospective review of the pathologic results for the remaining 43 patients (17 men, 26 women; mean age, years) showed 18 cases of an IPMN with either high-grade dysplasia or a coexistent invasive carcinoma. Most important, 37% (7/19 patients) had no CT findings of an invasive malignancy according to the Sendai criteria (i.e., cysts 3 cm in the axial plane, main pancreatic ductal dilatation 6 mm, or mural nodularity within a cyst) but were found to have an IPMN with either high-grade dysplasia or invasive carcinoma. When the pancreas contained 10 or more cysts, high-grade dysplasia or invasive carcinoma tended to be more likely than low- or intermediate-grade dysplasia (odds ratio, 3.83; 95% CI, ; p = 0.075). CONCLUSION. The presence of multiple pancreatic cysts should be looked on with suspicion, particularly when there are a large number of cysts, even when none of the cysts individually meet the imaging criteria for resection according to the Sendai consensus recommendations. At the very least, these patients need to be followed very closely. A s a result of improvements in MDCT over the past decade, as well as the development of 3D reconstruction techniques, it has become a routine part of daily practice to identify small cystic lesions in the pancreas. Moreover, the efficacy of MRI and endoscopic ultrasound in depicting these small incidental cysts has proven to be even greater than that of CT, and both of these modalities have gradually begun playing larger roles in evaluating the pancreas [1]. Most of these pancreatic cysts are small side-branch intraductal papillary mucinous neoplasms (IPMNs), mucin-producing pancreatic lesions that arise in and can produce dilatation of the main pancreatic duct, side branches, or both [1, 2]. Side-branch IPMNs have a lower risk of associated invasive carcinoma (6 51%) than main duct IPMNs, and as a result, there has been debate regarding the management of these lesions [1]. The Sendai consensus statement issued in 2006 by Tanaka et al. [3] established a number of criteria for the resection of pancreatic side-branch IPMNs, including an axial diameter of 30 mm or greater, main pancreatic ductal dilatation of 6 mm or greater, and mural nodularity within a cyst. Several subsequent studies have validated these criteria and have suggested that patient symptoms and elevated tumor marker levels (e.g., cancer antigen [CA] 19-9) are also suspicious features that may indicate cyst resection is warranted [2]. AJR:200, March

2 Raman et al. However, as imaging technology has improved, it has become increasingly common to visualize multiple side-branch IPMNs and it is also now common for pathologists to identify multifocal IPMNs in histologic specimens [4, 5] (Fig. 1). Although there are many articles in the literature about the management of a single isolated pancreatic side-branch IPMN, there are few about the management of multiple pancreatic cysts particularly when none of the individual cysts meet the Sendai criteria for resection. The aim of this study was to establish the likelihood of lesions with high-grade dysplasia or invasive carcinoma when there are multiple pancreatic IPMNs on MDCT. Materials and Methods Study Preparation and Patient Population Before commencement of this study, permission was obtained from our institutional review board. Patient informed consent was not required. A search was then performed of the surgery department computer database for all IPMNs surgically resected from 1998 to The available CT scans for each of these 279 patients were retrospectively reviewed by an abdominal radiologist, and a total of 52 patients were found to have four or more cystic lesions in the pancreas. This group of patients formed the study population and was composed of 19 men and 33 women. The 52 patients had a mean age of 71.8 years and a median age of 72 years. Thirty patients underwent a Whipple procedure (pancreaticoduodenectomy), 12 patients underwent distal pancreatectomy, and 10 patients underwent total pancreatectomy. Fig year-old man with innumerable cysts throughout pancreas on axial contrast-enhanced CT image. No cysts measured more than 3 cm, no solid pancreatic mass was identified, and no individual cyst was found to have mural nodularity. Invasive colloid carcinoma was discovered after total pancreatectomy. CT Technique All MDCT examinations were performed on one of four scanners, all of which were manufactured by Siemens Healthcare, in use at our institution during the time course of the study: Somatom Plus 4 Volume Zoom scanner (detector collimation, 4 1 mm; reconstruction, 3-mm slice thickness; 120 kvp; mas), Somatom Sensation 16 (detector collimation, mm; reconstruction for diagnostic interpretation, 3-mm slice thickness and 3-mm slice intervals; reconstruction for multiplanar reformation [MPR], 0.75-mm slice thickness and 0.5-mm intervals; 120 kvp; mas), Somatom Sensation 64 (detector collimation, mm; reconstruction for diagnostic interpretation, 3-mm slice thickness and 3-mm slice intervals; reconstruction for MPR, 0.75-mm slice thickness and 0.5-mm intervals; 120 kvp; mas), and Somatom Definition Flash dual-source (detector collimation, mm; reconstruction for diagnostic interpretation, 3-mm slice thickness and 3-mm slice intervals; reconstruction for MPR, 0.75-mm slice thickness and 0.5-mm intervals; 120 kvp; quality reference, 290 mas for online dose modulation system [CareDose 4D, Siemens Healthcare]). All patients, regardless of which scanner was being used, ingested ml of water over the 15- to 20-minute period before scanning commenced. In all cases, a scout topogram was acquired, followed by the acquisition of arterial and venous phase images at and seconds, respectively, after the administration of IV contrast material. Iohexol (Omnipaque 350, GE Healthcare), 120 ml, was injected IV rapidly through a peripheral vein at 3 5 ml/s. All image data were reconstructed using a body soft-tissue algorithm. All studies were interpreted on a PACS workstation (Ultravisual PACS, version , Emageon). The studies acquired on the Somatom Sensation 16, Somatom Sensation 64, and Somatom Definition Flash dual-source scanners included automatically reconstructed coronal and sagittal reformations. The oldest studies acquired on the Somatom Plus 4 Volume Zoom scanner did not include automatically reconstructed reformations, and reformats were manually created by the reviewing radiologists on the PACS workstation using the Ultravisual PACS software package. Image Analysis The CT scans for each of the 52 patients in the study were independently read by two radiologists with subspecialization training in abdominal imaging. The more senior of the two radiologists had 14 years of postfellowship experience, and the second radiologist had 1 year of postfellowship experience. After the cases were independently read by each of the two radiologists, the studies were read by the two readers in consensus to resolve any discrepancies. The abdominal radiologists reviewing the studies were blinded to the pathologic results for each patient when reviewing the CT scans. The following parameters were evaluated for each CT examination: number of cysts in the pancreas, size of the five (if applicable) largest cysts in the pancreas, presence of mural nodularity within any of the cysts, presence of a separate solid mass within the pancreas, main pancreatic ductal dilatation (defined as present if any portion of the pancreatic duct is 6 mm) and duct size, presence of either thin septations ( 3 mm in thickness) or thick septations (> 3 mm), and presence of biliary dilatation (common bile duct measuring > 1 cm) or presence of a biliary stent. Pathology The postsurgical pathology records were then retrospectively searched for each patient, and the results were placed into one of four categories on the basis of the most recent World Health Organization classification for IPMN [6]: IPMN with low-grade dysplasia, IPMN with intermediategrade dysplasia, IPMN with high-grade dysplasia, or IPMN with an associated invasive carcinoma. Each of the pathology results was interpreted by a board-certified pathologist with subspecialty training in surgical pathology and a subspecialty focus in gastrointestinal and pancreatic diseases. Statistical Evaluation For the purposes of analysis, IPMN with lowgrade dysplasia and IPMN with intermediate-grade dysplasia were grouped together, as were IPMN with high-grade dysplasia and IPMN with invasive carcinoma. s of these groups were compared using the Fisher exact test for categoric outcomes and Wilcoxon rank sum test for continuous outcomes. To identify CT features that were associated with having high-grade dysplasia or invasive carcinoma, we used multivariate logistic regression models that adjusted for patient age and sex and we ran the models with high-grade dysplasia or invasive carcinoma as the 564 AJR:200, March 2013

3 CT of Multifocal Pancreatic IPMNs dependent variable and different CT features as independent variables. Analyses were completed with statistical freeware (R, version , The R Project for Statistical Computing). All p values < 0.05 were considered statistically significant. Results Of the 52 patients in the study population, nine were found to have a distinct solid pancreatic mass on CT in addition to their pancreatic cysts. The characteristics of these patients are summarized in Table 1; all nine patients were found to have invasive carcinoma after surgical resection. The mean maximum axial diameter of these solid masses was 2.5 cm with a median maximum axial diameter of 2.5 cm. Table 2 summarizes the remaining 43 patients, none of whom had evidence of a solid pancreatic mass on CT. This group of patients had a mean number of pancreatic cysts of 14.1 and a median number of cysts of 9. Eighteen of the 43 patients (41.9%) in this group had evidence of high-grade dysplasia or coexistent invasive carcinoma. Notably, of the patients in this group, 15 patients had pancreatic ductal dilatation of 6 mm or greater, six patients had evidence of mural nodularity within at least one pancreatic cyst, 18 had evidence of a septation within at least one cyst, and 12 had evidence of at least one cyst measuring 3 cm or larger in the axial plane. Table 3 summarizes the patients with and those without high-grade dysplasia or invasive carcinoma. Notably, no statistically significant differences could be identified between the two groups with regard to mural nodularity within a cyst (p = 0.68), thin septations (p > 0.99), thick septations (p = 0.42), cyst calcification (p = 0.17), or a cyst size of 3 cm or larger (p > 0.99). Although the proportions of patients with main pancreatic duct sizes of 3 mm or greater, 6 mm or greater, and 7 mm or greater were not significantly different between the two groups, patients with high-grade dysplasia or invasive carcinoma had significantly (p = 0.03) larger duct sizes overall (median, 5.2 mm; range, 1 27 mm) compared with patients with low-grade or intermediate-grade dysplasia (median, 4.5 mm; range, 1 8 mm). A greater proportion of patients with highgrade dysplasia or invasive carcinoma compared with patients with low- or intermediate-grade dysplasia (67% v 32%) had 10 or more pancreatic cysts (p = 0.03). The difference between the two groups trended toward significance for patients with 20 cysts or more (33% vs 8%, p = 0.05). Table 4 summarizes the results of regression models examining the associations between high-grade dysplasia and invasive carcinoma and various CT characteristics. Mural nodularity, cyst size of 3 cm or larger in the axial plane, septations (thin or thick), biliary ductal dilatation (for those lesions in the head or uncinate process), or calcifications were not found to be significantly associated with high-grade dysplasia and invasive carcinoma. Patients with a main pancreatic duct of 6 mm or larger (odds ratio [OR], 4.9; 95% CI, ; p = 0.06), 10 or more cysts (OR = 3.8; 95% CI, ; p = 0.08), and 20 or more cysts (OR = 13.7; 95% CI, ; p = 0.02) showed trends toward being more likely to have high-grade dysplasia or invasive carcinoma. TABLE 1: Nine Cases of Multiple Pancreatic Cysts With a Discrete Solid Mass Identified on CT Value Sex, no. of patients Male 2 Female 7 Age (y) Mean Median 76 Surgeries, no. of patients Pancreaticoduodenectomy 4 Distal pancreatectomy 3 Total pancreatectomy 2 Mean (SD) 18 (16.4) Median (range) 10 (7 60) Histologic diagnosis, no. (%) of patients Ductal adenocarcinoma with IPMN 9 (100) Note IPMN = intraductal papillary mucinous neoplasm. TABLE 2: Forty-Three Patients With Four or More Pancreatic Cysts But No Discrete Solid Mass on CT Value Sex, no. of patients Male 17 Female 26 Age (y) Mean Median 71 Surgeries, no. of patients Pancreaticoduodenectomy 26 Distal pancreatectomy 9 Total pancreatectomy 8 Mean (SD) 14.1 (16.8) Median (range) 9 (4 100) Histologic diagnosis, no. (%) of patients Low- or intermediate-grade dysplasia 25 (58.1) High-grade dysplasia or invasive carcinoma 18 (41.9) AJR:200, March

4 Raman et al. TABLE 3: s of Patients by Grade of Dysplasia Table 5 summarizes the characteristics of the 19 patients in the study who did not meet any of the Sendai consensus statement s imaging guidelines for cyst resection, including a cyst measuring 3 cm or larger in the axial dimension, mural nodularity, or main pancreatic ductal dilatation of 6 mm or greater. This group of patients was found to have seven cases (37%) of either high-grade dysplasia or invasive carcinoma. Low- or Moderate-Grade Dysplasia (n = 25) Discussion The management of main duct IPMNs has become fairly well established: It is recommended that all main duct IPMNs be resected. Although there has been some debate regarding the management of side-branch IPMNs, the Sendai consensus statement in 2006 [3] established imaging criteria for their resection, including a maximum axial diameter of 3 cm or greater, dilatation of the main pancreatic duct of 6 mm or more, and internal mural nodularity [2, 3, 7 12]. Several additional criteria have been proposed in the literature including patient symptoms, biliary duct obstruction, elevated CA19-9 level, and abnormal cytologic results after endoscopic ultrasound guided cyst aspiration. These criteria were thought to denote cysts with a greater likelihood of containing foci of high-grade dysplasia or invasive carcinoma [13, 14]. Conversely, although there is some ambiguity in the literature, most small cysts not meeting these criteria (i.e., simple cysts < 3 cm) are thought to be safe to observe [15, 16]. Accordingly, the risk of invasive carcinoma in side-branch IPMNs and small pancreatic cysts has been extensively studied in the literature: Sahani et al. [17, 18] reported 87% of pancreatic cysts smaller than 3 cm were benign and that 97% of small unilocular cysts were benign. Lee et al. [19] reported that only 31 of 166 pancreatic cysts (19%) High-Grade Dysplasia or Invasive Carcinoma (n = 18) Biliary ductal dilatation or stent, no. (%) of patients 2 (18) a 5 (56) a 0.16 Age (y) Median (range) 68 (50 89) 78 (65 89) Sex, no. of patients > 0.99 Male 10 (40) 7 (39) Female 15 (60) 11 (61) At least one cyst, no. (%) of patients 3 cm 7 (28) 5 (28) > 0.99 With mural nodularity 3 (12) 3 (17) With septation 10 (40) 8 (44) > 0.99 With thin septation 10 (40) 8 (44) > 0.99 With thick septation 0 (0) 1 (6) With calcification 0 (0) 2 (11) MPD 3 mm 16 (64) 16 (89) MPD 6 mm 6 (24) 9 (50) MPD 7 mm 6 (24) 8 (44) MPD size (mm) Median (range) 4.5 (1 8) 5.2 (1 27) per patient, no. (%) of patients 5 22 (88) 17 (94) (32) 12 (67) (8) 6 (33) Median (range) 8 (4 50) 12 (4 100) Note MPD = main pancreatic duct. a The impact of biliary dilatation including those patients with a stent was analyzed only for lesions in the pancreatic head or uncinate process: n = 11 for low- or moderate-grade dysplasia and n = 9 for high-grade dysplasia or invasive carcinoma. regardless of morphology were malignant. In terms of studies looking specifically at side-branch IPMNs, most do not specifically distinguish between unifocal and multifocal IPMNs in their series, but many have shown fairly low rates of malignancy for sidebranch IPMNs. Schmidt et al. [14] found an 18% malignancy rate with regard to unifocal IPMN. In their series of 43 patients with sidebranch IPMN, Terris et al. [20] found no cases of invasive carcinoma and only 15% had evidence of high-grade dysplasia. Matsumoto et al. [21] found no cases of invasive carcinoma or high-grade dysplasia in their series of patients with side-branch IPMN measuring less than 30 mm without mural nodularity. In a series by Sugiyama et al. [22], none of the patients with side-branch IPMN was found to have invasive carcinoma. However, as MDCT technology has improved, it has become increasingly common to visualize multiple side-branch IPMNs in the p 566 AJR:200, March 2013

5 CT of Multifocal Pancreatic IPMNs pancreas. This is concordant with the results of histopathologic studies, which have noted that IPMN can often be multifocal, with rates perhaps ranging as high as 25% (depending on the method used) [4]. Moreover, even when additional IPMNs are not initially visualized TABLE 4: Odds Ratios Adjusted for Patient Age and Sex for the Association Between Different CT s and High-Grade Dysplasia or Invasive Carcinoma Odds Ratio 95% CI p Sensitivity Specificity Biliary ductal dilatation or stent Yes At least one cyst 3 cm Yes At least one cyst with mural nodularity Yes At least one cyst with septation Yes At least one cyst with thin septation Yes At least one cyst with thick septation Yes 0 to infinity At least one cyst with calcification Yes 0 to infinity MPD size < 3 mm 1 3 mm MPD size < 6 mm 1 6 mm MPD size < 7 mm 1 7 mm < < < Note Dash ( ) indicates not applicable. MPD = main pancreatic duct. on CT, Sohn et al. [7] noted the development of either invasive or noninvasive IPMN in the pancreatic remnant of several patients after resection of a noninvasive IPMN, a result confirmed in at least one other study. The presence of completely negative margins in the pathologic samples of that study suggests that these recurrences were not secondary to the presence of residual dysplastic tissue after surgery but, rather, were due to multifocal disease [7, 23]. Interestingly, a study by Chari et al. [24] noted no recurrences after total pancreatectomy. It is unclear if these multifocal pancreatic IPMNs are clonally related tumors arising from a single progenitor neoplasm that grows throughout the ductal system, if they reflect the development of multiple unrelated lesions within a ductal epithelium that may be genetically predisposed to the development of neoplasms, or if they reflect the development of multiple neoplasms due to genetic chance [4]. At least one genetic study of histopathologic specimens in patients with known multifocal side-branch IPMNs has shown distinct genetic alterations within different cysts in the same patient, suggesting that these multiple lesions are the result of several distinct genetic events [4]. Investigators have suggested that the multicentric model of IPMN development may reflect hyperplasia and dysplasia in different branch ducts due to different KRAS mutations, a genetic marker thought to be highly specific for detecting a mucinous neoplasm [25, 26]. Nevertheless, the proper management of multifocal IPMNs, when visualized on CT, has not been extensively studied in the literature, with only a few series detailing the association between IPMN multifocality and malignancy. Salvia et al. [4] examined 131 patients with multifocal side-branch IPMNs, roughly 8% of whom underwent surgery. Forty months after surgery, disease in every conservatively managed patient was radiographically stable without evidence of progressive disease and only one of the surgically managed patients had evidence of invasive carcinoma [4]. In their study looking at 145 patients with side-branch IPMN, Rodriguez et al. [27] reported that roughly 25% were found to have some evidence of multifocality on histologic specimens, with no statistically significant difference between the benign and malignant groups. In a study by Schmidt et al. [14], multifocality was identified in 41% of pathologic specimens, but there was no statistically significant difference in ma- AJR:200, March

6 Raman et al. TABLE 5: Nineteen Patients With Four or More Pancreatic Cysts But With No Single Cyst Meeting the Sendai Imaging Criteria [3] for Resection a lignancy between the unifocal (18%) and multifocal (7%) groups. A pathologic study of specimens with multifocal side-branch IPMNs has found that most of lesions are of the gastric-foveolar histologic subtypes and generally contain low- to intermediate-grade dysplasia with a lesser risk of high-grade dysplasia or invasive carcinoma [5]. Although no consensus protocol has emerged regarding the management of these multifocal lesions, the aforementioned studies have suggested that no distinct management algorithm is needed for multifocal disease and that the Sendai criteria should be applied individually to each cyst in the pancreas [2, 4]. However, most studies advocate close radiologic surveillance of these patients especially given the practical difficulties in the surgical management of multiple pancreatic lesions that may involve all portions of the pancreas [4]. However, the results of this study suggest the possibility that the presence of multiple side-branch IPMNs should be considered as a suspicious feature. Notably, of the 43 patients in our study with multifocal disease ( 4 pancreatic cysts), 18 of the 43 (41.9%) had evidence of high-grade dysplasia (19%) or invasive carcinoma (23%) despite the failure to visualize a discrete soft-tissue mass in any of the patients. This result represents a higher percentage of patients compared with other studies that have looked solely at unifocal side-branch IPMN. Moreover, logistic regression models with high-grade dysplasia or invasive carcinoma as the outcome found 20 cysts Value Sex, no. of patients Male 7 Female 12 Age (y) Mean 71.7 Median 71 Surgeries, no. of patients Pancreaticoduodenectomy 15 Distal pancreatectomy 2 Total pancreatectomy 2 Histologic diagnosis, no. (%) of patients Low- or intermediate-grade dysplasia 12 (63) High-grade dysplasia or invasive carcinoma 7 (37) a That is, no cyst 3 cm in axial dimension, no cyst with mural nodularity, no pancreatic ductal dilatation 6 mm. or more to be significantly associated with the outcome (OR, 13.7; p = 0.02), and 10 cysts or more trended toward significance (OR, 3.8; p = 0.07) (Table 4). In addition, a significantly larger percentage of patients with high-grade dysplasia or invasive carcinoma were found to have 10 cysts or more, and the median number of cysts in patients with high-grade dysplasia or invasive carcinoma was significantly higher than in those with low- or intermediate-grade dysplasia (Table 3). These analyses are limited by the small sample size, however, and should be validated in larger populations. Perhaps most important is that a total of 19 patients did not meet any of the Sendai consensus statement s imaging parameters for resection (i.e., cyst size 3 cm in the axial plane, mural nodularity, main pancreatic duct dilatation 6 mm) and seven (37%) of these patients had evidence of high-grade dysplasia or invasive carcinoma (Table 5). Clearly, the strict application of the Sendai imaging criteria to many of these cases may have inappropriately led to surveillance of lesions that deserved surgical resection. Several confounding elements must be considered. First, although the number of cases of high-grade dysplasia or invasive carcinoma in our study is certainly concerning, we did not perform a comparison with patients with a solitary pancreatic cyst. Second, only eight of 43 patients in this study underwent total pancreatectomy, with the remaining undergoing either a Whipple procedure or distal pancreatectomy. Given the presence of multiple cysts in all parts of the pancreas in many of these cases, it is unclear whether the pathologic results for the resected portions of the pancreas are reflective of the unresected portions of the pancreas [7]. It is conceivable that this study could be underestimating the degree of significant dysplasia within a pancreas with multifocal disease. Moreover, we did not include analysis of those cases with a remnant pancreas after surgery in this study, and it is possible that some of these patients developed progressive disease in their pancreatic remnant after surgery. Third, every case in this study underwent surgery and we did not look at patients merely undergoing surveillance. It is likely that this exclusion biases the results toward significant dysplasia or carcinoma. Moreover, we only studied the Sendai imaging criteria for resection and did not look at patient symptoms, endoscopic ultrasound results, or tumor markers, all of which are undoubtedly also important factors in the decision to operate. Ultimately, however, the presence of multiple pancreatic cysts may need to be viewed with added suspicion even when none of the cysts individually meet size or resection criteria according to the Sendai consensus. The presence of high-grade dysplasia or invasive carcinoma cannot be excluded in these specimens particularly when confronted with a large number of cysts. It is important not to be too cavalier about the risks associated with surgery: Even in the highest-volume centers, there is significant morbidity and mortality associated with the Whipple procedure or total pancreatectomy. Nevertheless, surgery may be an important option in many of these patients, although total pancreatectomy is currently reserved for the most concerning cases as a result of its significant physiologic impact [7]. Moreover, if surveillance is chosen, it is important not to rely solely on CT because many of the cases of invasive carcinoma in this study were completely unsuspected on the basis of CT; surveillance with endoscopic ultrasound, tumor markers, or both may be equally important. From a radiology perspective, given the proven advantages of MRI with regard to evaluation of the morphology and internal architecture of cysts, MRI may be a valuable component of follow-up in these patients for whom CT clearly shows limitations [28]. References 1. Canto MI, Hruban RH, Fishman EK, et al.; American Cancer of the Pancreas Screening (CAPS) Consortium. Frequent detection of pan- 568 AJR:200, March 2013

7 CT of Multifocal Pancreatic IPMNs creatic lesions in asymptomatic high-risk individuals. Gastroenterology 2012; 142: Nagai K, Doi R, Kida A, et al. Intraductal papillary mucinous neoplasms of the pancreas: clinicopathologic characteristics and long-term followup after resection. World J Surg 2008; 32: ; discussion, Tanaka M, Chari S, Adsay V, et al.; International Association of Pancreatology. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006; 6: Salvia R, Partelli S, Crippa S, et al. Intraductal papillary mucinous neoplasms of the pancreas with multifocal involvement of branch ducts. Am J Surg 2009; 198: Matthaei H, Norris AL, Tsiatis AC, et al. Clinicopathologic characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2012; 255: Ohtsuka T, Kono H, Nagayoshi Y, et al. An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas. Surgery 2012; 151: Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 2004; 239: ; discussion, Uehara H, Ishikawa K, Kawada N, et al. Size of mural nodule as an indicator of surgery for branch duct intraductal papillary mucinous neoplasm of the pancreas during follow-up. J Gastroenterol 2011; 46: Tanaka M. Controversies in the management of pancreatic IPMN. Nat Rev Gastroenterol Hepatol 2011; 8: Sadakari Y, Ienaga J, Kobayashi K, et al. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules. Pancreas 2010; 39: Nagai K, Doi R, Ito T, et al. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Surg 2009; 16: Kawamoto S, Lawler LP, Horton KM, Eng J, Hruban RH, Fishman EK. MDCT of intraductal papillary mucinous neoplasms of the pancreas: evaluation of features predictive of invasive carcinoma. AJR 2006; 186: Sugiyama M, Suzuki Y, Mori T, Atomi Y. Management of intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol 2008; 43: Schmidt CM, White PB, Waters JA, et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg 2007; 246: Walsh RM, Vogt DP, Henderson JM, et al. Management of suspected pancreatic cystic neoplasms based on cyst size. Surgery 2008; 144: Bernard P, Scoazec J, Joubert M, et al. Intraductal papillary-mucinous tumors of the pancreas: predictive criteria of malignancy according to pathological examination of 53 cases. Arch Surg 2002; 137: Sahani DV, Miller JC, Fernandez del Castillo C, Brugge WR, Thrall JH, Lee SI. Cystic pancreatic lesions: classification and management. J Am Coll Radiol 2009; 6: Sahani DV, Saokar A, Hahn PF, et al. Pancreatic cysts 3 cm or smaller: how aggressive should treatment be? Radiology 2006; 238: Lee CJ, Scheiman J, Anderson MA, et al. Risk of malignancy in resected cystic tumors of the pancreas < 3 cm in size: is it safe to observe asymptomatic patients? A multi-institution report. J Gastrointest Surg 2008; 12: Terris B, Ponsot P, Paye F, et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol 2000; 24: Matsumoto T, Aramaki M, Yada K, et al. Optimal management of the branch duct type intraductal papillary mucinous neoplasms of the pancreas. J Clin Gastroenterol 2003; 36: Sugiyama M, Izumisato Y, Abe N, Masaki T, Mori T, Atomi Y. Predictive factors for malignancy in intraductal papillary-mucinous tumors of the pancreas. Br J Surg 2003; 90: Nagai E, Ueki T, Chijiwa K, et al. Intraductal papillary mucinous neoplasms of the pancreas associated with so-called mucinous ductal ectasia : histochemical and immunohistochemical analysis of 29 cases. Am J Surg Pathol 1995; 19: Chari ST, Yadav D, Smyrk TC, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology 2002; 123: Izawa T, Obara T, Tanno S, Mizukami Y, Yanagawa N, Kohgo Y. Clonality and field cancerization in intraductal papillary mucinous tumors of the pancreas. Cancer 2001; 92: Jani N, Bani Hani M, Schulick RD, Hruban RH, Cunningham SC. Diagnosis and management of cystic lesions of the pancreas. Diagn Ther Endosc 2011; 2011: Rodriguez JR, Salvia R, Crippa S, et al. Branch duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resections. Gastroenterology 2007; 133: Macari M, Lee T, Kim S, et al. Is gadolinium necessary for MRI follow-up evaluation of cystic lesions in the pancreas? Preliminary results. AJR 2009; 192: AJR:200, March

Intraductal papillary mucinous neoplasm (IPMN) is a distinct

Intraductal papillary mucinous neoplasm (IPMN) is a distinct CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2008;6:815 819 Evaluation of the Guidelines for Management of Pancreatic Branch-Duct Intraductal Papillary Mucinous Neoplasm RAYMOND S. TANG,* BENJAMIN WEINBERG,

More information

Outline. Intraductal Papillary Mucinous Neoplasm (IPMN) Guideline Review 4/6/2017. Case Example Background Classification Histology Guidelines

Outline. Intraductal Papillary Mucinous Neoplasm (IPMN) Guideline Review 4/6/2017. Case Example Background Classification Histology Guidelines Intraductal Papillary Mucinous Neoplasm (IPMN) Guideline Review The Nurse Practitioner Association New York State Capital Region Teaching Day Matthew Warndorf MD Case Example Background Classification

More information

Predictive factors for invasive intraductal papillary mucinous neoplasm of the pancreas

Predictive factors for invasive intraductal papillary mucinous neoplasm of the pancreas Korean J Hepatobiliary Pancreat Surg 2011;15:27-22 Original Article Predictive factors for invasive intraductal papillary mucinous neoplasm of the pancreas Dae Young Jun 1, Hyung Jun Kwon 2, Sang Geol

More information

Management A Guideline Based Approach to the Incidental Pancreatic Cysts. Common Cystic Pancreatic Neoplasms.

Management A Guideline Based Approach to the Incidental Pancreatic Cysts. Common Cystic Pancreatic Neoplasms. Management 2016 A Guideline Based Approach to the Incidental Pancreatic Cysts ISMRM 2016 Masoom Haider, MD, FRCP(C) Professor of Radiology, University of Toronto Clinician Scientist, Ontario Institute

More information

ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts

ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts Grace H. Elta, MD, FACG 1, Brintha K. Enestvedt, MD, MBA 2, Bryan G. Sauer, MD, MSc, FACG (GRADE Methodologist) 3 and Anne Marie Lennon,

More information

Pancreatic Cysts. Darius C. Desai, MD FACS St. Luke s University Health Network

Pancreatic Cysts. Darius C. Desai, MD FACS St. Luke s University Health Network Pancreatic Cysts Darius C. Desai, MD FACS St. Luke s University Health Network None Disclosures Incidence Widespread use of cross sectional imaging Seen in over 2% of patients having abdominal imaging

More information

Branch duct intraductal papillary mucinous neoplasm of the pancreas: single-center experience with 324 patients who underwent surgical resection

Branch duct intraductal papillary mucinous neoplasm of the pancreas: single-center experience with 324 patients who underwent surgical resection Korean J Hepatobiliary Pancreat Surg 2015;19:113-120 http://dx.doi.org/10.14701/kjhbps.2015.19.3.113 Original Article Branch duct intraductal papillary mucinous neoplasm of the pancreas: single-center

More information

ORIGINAL ARTICLE. Fate of the Pancreatic Remnant After Resection for an Intraductal Papillary Mucinous Neoplasm

ORIGINAL ARTICLE. Fate of the Pancreatic Remnant After Resection for an Intraductal Papillary Mucinous Neoplasm ONLINE FIRST ORIGINAL ARTICLE Fate of the Pancreatic Remnant After Resection for an Intraductal Papillary Mucinous Neoplasm A Longitudinal Level II Cohort Study Toshiyuki Moriya, MD, PhD; L. William Traverso,

More information

Citation American Journal of Surgery, 196(5)

Citation American Journal of Surgery, 196(5) NAOSITE: Nagasaki University's Ac Title Author(s) Multifocal branch-duct pancreatic i neoplasms Tajima, Yoshitsugu; Kuroki, Tamotsu Amane; Adachi, Tomohiko; Mishima, T Kanematsu, Takashi Citation American

More information

PAPER. Experience With 208 Resections for Intraductal Papillary Mucinous Neoplasm of the Pancreas

PAPER. Experience With 208 Resections for Intraductal Papillary Mucinous Neoplasm of the Pancreas PAPER Experience With 0 Resections for Intraductal Papillary Mucinous Neoplasm of the Pancreas Thomas Schnelldorfer, MD; Michael G. Sarr, MD; David M. Nagorney, MD; Lizhi Zhang, MD; Thomas C. Smyrk, MD;

More information

Surgical outcomes of multifocal branch duct intraductal papillary mucinous neoplasms of pancreas

Surgical outcomes of multifocal branch duct intraductal papillary mucinous neoplasms of pancreas Korean J Hepatobiliary Pancreat Surg 2014;18:152-158 http://dx.doi.org/10.14701/kjhbps.2014.18.4.152 Original Article Surgical outcomes of multifocal branch duct intraductal papillary mucinous neoplasms

More information

Evaluation of AGA and Fukuoka Guidelines for EUS and surgical resection of incidental pancreatic cysts

Evaluation of AGA and Fukuoka Guidelines for EUS and surgical resection of incidental pancreatic cysts Evaluation of AGA and Fukuoka Guidelines for EUS and surgical resection of incidental pancreatic cysts Authors Alexander Lee 1, Vivek Kadiyala 2,LindaS.Lee 3 Institutions 1 Texas Digestive Disease Consultants,

More information

Cystic Pancreatic Lesions: Approach to Diagnosis

Cystic Pancreatic Lesions: Approach to Diagnosis Cystic Pancreatic Lesions: Approach to Diagnosis Poster No.: R-0130 Congress: RANZCR-AOCR 2012 Type: Educational Exhibit Authors: A. AGARWAL, R. M. Mendelson; Perth/AU Keywords: Cysts, Biopsy, Endoscopy,

More information

A Multicentric Development Of Intraductal Papillary Mucinous Neoplasm Treated By Repeated Pancreatectomy

A Multicentric Development Of Intraductal Papillary Mucinous Neoplasm Treated By Repeated Pancreatectomy ISPUB.COM The Internet Journal of Surgery Volume 7 Number 2 A Multicentric Development Of Intraductal Papillary Mucinous Neoplasm Treated By Repeated T Matsumoto, K Iwaki, H Uchida, K Yada, K Shibata,

More information

PersPeCTIves. Controversies in the management of pancreatic ipmn. Masao Tanaka

PersPeCTIves. Controversies in the management of pancreatic ipmn. Masao Tanaka PersPeCTIves OpiniOn Controversies in the management of pancreatic ipmn Masao Tanaka Abstract Although considerable progress has been made in our understanding of intraductal papillary mucinous neoplasm

More information

SYSTEMATIC REVIEWS AND META-ANALYSES

SYSTEMATIC REVIEWS AND META-ANALYSES CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2013;11:913 921 SYSTEMATIC REVIEWS AND META-ANALYSES Fasiha Kanwal, Section Editor Cyst Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasms

More information

An Approach to Pancreatic Cysts. Introduction

An Approach to Pancreatic Cysts. Introduction An Approach to Pancreatic Cysts Nalini M. Guda, MD Aurora St. Luke s Medical Center, Milwaukee Clinical Adjunct Professor of Medicine, University of Wisconsin School of Medicine and Public Health Introduction

More information

According to the international consensus guidelines for

According to the international consensus guidelines for ORIGINAL ARTICLE Natural History of Branch Duct Intraductal Papillary Mucinous Neoplasm With Mural Nodules A Japan Pancreas Society Multicenter Study Go Kobayashi, MD, PhD,* Naotaka Fujita, MD, PhD,* Hiroyuki

More information

A large mural nodule in branch duct intraductal papillary mucinous adenoma of the pancreas: a case report

A large mural nodule in branch duct intraductal papillary mucinous adenoma of the pancreas: a case report Haruki et al. Surgical Case Reports (2015) 1:20 DOI 10.1186/s40792-014-0009-x CASE REPORT Open Access A large mural nodule in branch duct intraductal papillary mucinous adenoma of the pancreas: a case

More information

Mucin-Producing Neoplasms of the Pancreas: An Analysis of Distinguishing Clinical and Epidemiologic Characteristics

Mucin-Producing Neoplasms of the Pancreas: An Analysis of Distinguishing Clinical and Epidemiologic Characteristics Mucin-Producing Neoplasms of the Pancreas: An Analysis of Distinguishing Clinical and Epidemiologic Characteristics The Harvard community has made this article openly available. Please share how this access

More information

Matthew McCollough, M.D. April 9, 2009 University of Louisville

Matthew McCollough, M.D. April 9, 2009 University of Louisville Matthew McCollough, M.D. April 9, 2009 University of Louisville List the differential diagnosis for pancreatic cysts Review the epidemiology Illustrate the types of cysts through case discussions Discuss

More information

Select problems in cystic pancreatic lesions

Select problems in cystic pancreatic lesions Disclosure Select problems in cystic pancreatic lesions Five Prime Therapeutics shareholder Adicet Bio shareholder Bristol-Meyer Squibb advisory board grace.kim@ucsf.edu Pancreatic cystic lesions Intraductal

More information

Evaluation and Management of Cystic Lesions of the Pancreas: When to Resect, When to Follow and When to Forget

Evaluation and Management of Cystic Lesions of the Pancreas: When to Resect, When to Follow and When to Forget Evaluation and Management of Cystic Lesions of the Pancreas: When to Resect, When to Follow and When to Forget Randall Brand, MD Professor of Medicine Division of Gastroenterology, Hepatology and Nutrition

More information

Types of IPMN. Pancreas Cysts: An Incidental Finding or Harbinger of Malignancy. Cysts: Early Neoplasia. Mucinous Cystic Lesions. EUS-guided FNA EUS

Types of IPMN. Pancreas Cysts: An Incidental Finding or Harbinger of Malignancy. Cysts: Early Neoplasia. Mucinous Cystic Lesions. EUS-guided FNA EUS Pancreas Cysts: An Incidental Finding or Harbinger of Malignancy EUS-guided FNA William R. Brugge,, MD, FACG Professor of Medicine Harvard Medical School Director, GI Endoscopy Unit Massachusetts General

More information

Intraductal papillary mucinous neoplasm of the bile ducts: a rare form of premalignant lesion of invasive cholangiocarcinoma

Intraductal papillary mucinous neoplasm of the bile ducts: a rare form of premalignant lesion of invasive cholangiocarcinoma Intraductal papillary mucinous neoplasm of the bile ducts: a rare form of premalignant lesion of invasive cholangiocarcinoma Authors: R. Revert Espí, Y. Fernandez Nuñez, I. Carbonell, D. P. Gómez valencia,

More information

The role of endoscopy in the diagnosis and treatment of cystic pancreatic neoplasms

The role of endoscopy in the diagnosis and treatment of cystic pancreatic neoplasms The role of endoscopy in the diagnosis and treatment of cystic pancreatic neoplasms CYSTIC LESIONS AND FLUID COLLECTIONS OF THE PANCREAS Their pathology ranges from pseudocysts and pancreatic necrosis

More information

Chronic pancreatitis mimicking intraductal papillary mucinous neoplasm of the pancreas; Report of tow cases

Chronic pancreatitis mimicking intraductal papillary mucinous neoplasm of the pancreas; Report of tow cases Jichi Medical University Journal Chronic pancreatitis mimicking intraductal papillary mucinous neoplasm of the pancreas; Report of tow cases Noritoshi Mizuta, Hiroshi Noda, Nao Kakizawa, Nobuyuki Toyama,

More information

Intraductal Papillary Mucinous Neoplasm of the Pancreas. Masao Tanaka Editor

Intraductal Papillary Mucinous Neoplasm of the Pancreas. Masao Tanaka Editor Intraductal Papillary Mucinous Neoplasm of the Pancreas Masao Tanaka Editor Intraductal Papillary Mucinous Neoplasm of the Pancreas Masao Tanaka Editor Intraductal Papillary Mucinous Neoplasm of the Pancreas

More information

Intraductal Papillary Mucinous Neoplasms: The Bologna Experience

Intraductal Papillary Mucinous Neoplasms: The Bologna Experience ORIGINAL ARTICLE INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM Intraductal Papillary Mucinous Neoplasms: The Bologna Experience Riccardo Casadei 1, Carlo Alberto Pacilio 1, Claudio Ricci 1, Giovanni Taffurelli

More information

Cystic Lesions of the Pancreas: Changes in the Presentation and Management of 1,424 Patients at a Single Institution over a 15-Year Time Period

Cystic Lesions of the Pancreas: Changes in the Presentation and Management of 1,424 Patients at a Single Institution over a 15-Year Time Period Cystic Lesions of the Pancreas: Changes in the Presentation and Management of 1,424 Patients at a Single Institution over a 15-Year Time Period Sébastien Gaujoux, MD, PhD, Murray F Brennan, MD, FACS, Mithat

More information

Intraductal Papillary Mucinous Neoplasms: We Still Have a Way to Go! Francesco M. Serafini, MD, FACS

Intraductal Papillary Mucinous Neoplasms: We Still Have a Way to Go! Francesco M. Serafini, MD, FACS Intraductal Papillary Mucinous Neoplasms: We Still Have a Way to Go! Francesco M. Serafini, MD, FACS Brooklyn VAMC September 21 st GI Grand Rounds - What is it? - Clinical entity that has emerged from

More information

Newcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital

Newcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital Newcastle HPB MDM updated radiology imaging protocol recommendations Author Dr John Scott. Consultant Radiologist Freeman Hospital This document is intended as a guide to aid radiologists and clinicians

More information

CASE REPORT. Abstract. Introduction. Case Report

CASE REPORT. Abstract. Introduction. Case Report CASE REPORT Branch Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas Involving Type 1 Localized Autoimmune Pancreatitis with Normal Serum IgG4 Levels Successfully Diagnosed by Endoscopic Ultrasound-guided

More information

Contrast-Enhanced Ultrasonograpic Findings in Pancreatic Tumors

Contrast-Enhanced Ultrasonograpic Findings in Pancreatic Tumors Int. J. Med. Sci. 2008, 5 203 Short Research Communication International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2008 5(4):203-208 Ivyspring International Publisher. All rights reserved

More information

Patient History. A 58 year old man presents with a 16 mm cyst in the pancreatic tail. The cyst is unilocular with a thick wall and no mural nodule.

Patient History. A 58 year old man presents with a 16 mm cyst in the pancreatic tail. The cyst is unilocular with a thick wall and no mural nodule. Case 1 Martha Bishop Pitman, MD Director of Cytopathology Massachusetts General Hospital Associate Professor of Pathology Harvard Medical School Boston, MA Patient History A 58 year old man presents with

More information

1 Department of Gastroenterology and Pancreatology, Beaujon Hospital, France 3 Department or Radiology, Beaujon Hospital, University Paris 7, Clichy,

1 Department of Gastroenterology and Pancreatology, Beaujon Hospital, France 3 Department or Radiology, Beaujon Hospital, University Paris 7, Clichy, Original Article Accuracy of 2012 International Consensus Guidelines for the prediction of malignancy of branch-duct intraductal papillary mucinous neoplasms of the pancreas United European Gastroenterology

More information

Original article. Introduction!

Original article. Introduction! 382 Original article Peritoneal seeding in intraductal papillary mucinous neoplasm of the pancreas patients who underwent endoscopic ultrasound-guided fine-needle aspiration: The PIPE Study Authors Won

More information

Endoscopic Ultrasonography Clinical Impact. Giancarlo Caletti. Gastroenterologia Università di Bologna. Caletti

Endoscopic Ultrasonography Clinical Impact. Giancarlo Caletti. Gastroenterologia Università di Bologna. Caletti Clinical Impact Giancarlo Gastroenterologia Università di Bologna AUSL di Imola,, Castel S. Pietro Terme (BO) 1982 Indications Diagnosis of Submucosal Tumors (SMT) Staging of Neoplasms Evaluation of Pancreato-Biliary

More information

Wiriyaporn Ridtitid, John M.DeWitt, C. Max Schmidt, Alexandra Roch, Jennifer Schaffter Stuart, Stuart Sherman, Mohammad A.

Wiriyaporn Ridtitid, John M.DeWitt, C. Max Schmidt, Alexandra Roch, Jennifer Schaffter Stuart, Stuart Sherman, Mohammad A. Management of Branch duct Intraductal Papillary Mucinous Neoplasms: A Large Single Center Study to Assess Predictors of Malignancy and Long Term Outcomes Wiriyaporn Ridtitid, John M.DeWitt, C. Max Schmidt,

More information

Diagnosis and Management of Cystic Pancreatic Lesions

Diagnosis and Management of Cystic Pancreatic Lesions Gastrointestinal Imaging Best Practices/Review Sahani et al. Cystic Pancreatic Lesions Gastrointestinal Imaging Best Practices/Review Dushyant V. Sahani 1 Avinash Kambadakone 1 Michael Macari 2 Noaki Takahashi

More information

Hepatobiliary and Pancreatic Malignancies

Hepatobiliary and Pancreatic Malignancies Hepatobiliary and Pancreatic Malignancies Gareth Eeson MD MSc FRCSC Surgical Oncologist and General Surgeon Kelowna General Hospital Interior Health Consultant, Surgical Oncology BC Cancer Agency Centre

More information

Circulating Epithelial Cells in Intraductal Papillary Mucinous Neoplasms and Cystic Pancreatic Lesions

Circulating Epithelial Cells in Intraductal Papillary Mucinous Neoplasms and Cystic Pancreatic Lesions ORIGINAL ARTICLE Circulating Epithelial Cells in Intraductal Papillary Mucinous Neoplasms and Cystic Pancreatic Lesions Katherine E. Poruk, MD,* Vicente Valero, III, MD,* Jin He, MD,* Nita Ahuja, MD,*

More information

Gemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis

Gemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis GE Healthcare Gemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis CT clinical case study lesion characterization Desiree Morgan, MD Vice Chair of Clinical Research Professor

More information

Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms

Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms 22 Original article Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms Authors Ken Kamata 1, Masayuki Kitano 1, Masatoshi Kudo

More information

A pancreatic intraductal papillary mucinous neoplasm: A case report and literature review

A pancreatic intraductal papillary mucinous neoplasm: A case report and literature review Case report A pancreatic intraductal papillary mucinous neoplasm: A case report and literature review Martín A. Gómez Z., MD, 1 Cristian Melgar, MD, 2 Germán Junca, MD. 3 1 Gastroenterology Professor,

More information

A Selective Approach to Resection of Cystic Lesions of the Pancreas: Results From 539 Consecutive Patients

A Selective Approach to Resection of Cystic Lesions of the Pancreas: Results From 539 Consecutive Patients LETTER TO THE EDITOR A Selective Approach to Resection of Cystic Lesions of the Pancreas: Results From 539 Consecutive Patients To the Editor: I would like to congratulate Dr. Allen and colleagues for

More information

The Role of Molecular Analysis in the Diagnosis and Surveillance of Pancreatic Cystic Neoplasms

The Role of Molecular Analysis in the Diagnosis and Surveillance of Pancreatic Cystic Neoplasms JOP. J Pancreas (Online) 20 Mar 20; (2):-9. RESEARCH ARTICLE The Role of Molecular Analysis in the Diagnosis and Surveillance of Pancreatic Cystic Neoplasms Megan Winner, Amrita Sethi 2, John M Poneros

More information

Pancreatic Cystic Neoplasms: Guidelines and beyond

Pancreatic Cystic Neoplasms: Guidelines and beyond Pancreatic Cystic Neoplasms: Guidelines and beyond Kenneth J. Chang, MD, FACG, FASGE Executive Director, Comprehensive Digestive Disease Center Professor and Chief, Gastroenterology Vincent & Anna Kong

More information

5/17/2013. Pancreatic Cancer. Postgraduate Course in General Surgery CASE 1: CASE 1: Overview. Case presentation. Differential diagnosis

5/17/2013. Pancreatic Cancer. Postgraduate Course in General Surgery CASE 1: CASE 1: Overview. Case presentation. Differential diagnosis Overview Case presentation Postgraduate Course in General Surgery Differential diagnosis Diagnosis and therapy Eric K. Nakakura Koloa, HI March 26, 2013 Outcomes CASE 1: CASE 1: A 78-year-old man developed

More information

Objectives. Intraoperative Consultation of the Whipple Resection Specimen. Pancreas Anatomy. Pancreatic ductal carcinoma 11/10/2014

Objectives. Intraoperative Consultation of the Whipple Resection Specimen. Pancreas Anatomy. Pancreatic ductal carcinoma 11/10/2014 Intraoperative Consultation of the Whipple Resection Specimen Pathology Update Faculty of Medicine, University of Toronto November 15, 2014 John W. Wong, MD, FRCPC Department of Anatomical Pathology Sunnybrook

More information

CT Attenuation of Unilocular Pancreatic Cystic Lesions to Differentiate Pseudocysts from Mucin-Containing Cysts

CT Attenuation of Unilocular Pancreatic Cystic Lesions to Differentiate Pseudocysts from Mucin-Containing Cysts ORIGINAL ARTICLE CT Attenuation of Unilocular Pancreatic Cystic Lesions to Differentiate Pseudocysts from Mucin-Containing Cysts Hamid Chalian, Hüseyin Gürkan Töre, Frank H Miller, Vahid Yaghmai Department

More information

CT Differentiation of Mucin- Producing Cystic Neoplasms of the Liver From Solitary Bile Duct Cysts

CT Differentiation of Mucin- Producing Cystic Neoplasms of the Liver From Solitary Bile Duct Cysts Gastrointestinal Imaging Original Research Kim et al. CT of Hepatic Cystic Neoplasms and Cysts Gastrointestinal Imaging Original Research Hyoung Jung Kim 1 Eun Sil Yu 2 Jae Ho Byun 1 Seung-Mo Hong 2 Kyoung

More information

X-ray Corner. Imaging of The Pancreas. Pantongrag-Brown L

X-ray Corner. Imaging of The Pancreas. Pantongrag-Brown L X-ray Corner 125 Imaging of The Pancreas Modern imaging modalities commonly used in pancreas include ultrasound (US), CT, and MRI. Pancreas is a retroperitoneal organ which makes it difficult to visualize

More information

3/28/2012. Periampullary Tumors. Postgraduate Course in General Surgery CASE 1: CASE 1: Overview. Eric K. Nakakura Ko Olina, HI

3/28/2012. Periampullary Tumors. Postgraduate Course in General Surgery CASE 1: CASE 1: Overview. Eric K. Nakakura Ko Olina, HI Overview Postgraduate Course in General Surgery Case presentation Differential diagnosis Diagnosis and therapy Outcomes Principles of palliative care Eric K. Nakakura Ko Olina, HI March 27, 2012 CASE 1:

More information

High Prevalence of Pancreatic Cysts Detected by Screening Magnetic Resonance Imaging Examinations

High Prevalence of Pancreatic Cysts Detected by Screening Magnetic Resonance Imaging Examinations CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2010;8:806 811 High Prevalence of Pancreatic Cysts Detected by Screening Magnetic Resonance Imaging Examinations KOEN DE JONG,* C. YUNG NIO, JOHN J. HERMANS, MARCEL

More information

Cystic pancreatic lesions A proposal for a network approach. Chris Briggs Consultant HPB Surgeon Peninsula HPB Unit Derriford Hospital, Plymouth

Cystic pancreatic lesions A proposal for a network approach. Chris Briggs Consultant HPB Surgeon Peninsula HPB Unit Derriford Hospital, Plymouth Cystic pancreatic lesions A proposal for a network approach Chris Briggs Consultant HPB Surgeon Peninsula HPB Unit Derriford Hospital, Plymouth Aims Brief overview of cystic pancreatic lesions International

More information

Citation Hepato-Gastroenterology, 55(86-87),

Citation Hepato-Gastroenterology, 55(86-87), NAOSITE: Nagasaki University's Ac Title Author(s) Combined pancreatic resection and p multiple lesions of the pancreas: i of the pancreas concomitant with du Kuroki, Tamotsu; Tajima, Yoshitsugu Tomohiko;

More information

Pancreatic Disorders & Therapy

Pancreatic Disorders & Therapy ISSN: 2165-7092 rpancreatic Disorders & The apy Review Article Pancreatic Disorders & Therapy Kimura and Tezuka, 2015, 5:1 DOI: 10.4172/2165-7092.1000148 Open Access Acute Pancreatitis is a Predictive

More information

International consensus on the management of intraductal papillary mucinous neoplasm of the pancreas

International consensus on the management of intraductal papillary mucinous neoplasm of the pancreas Review Article Page 1 of 9 International consensus on the management of intraductal papillary mucinous neoplasm of the pancreas Masao Tanaka Shimonoseki City Hospital, 1-13-1 Koyo-cho, Shimonoseki 750-8520,

More information

Mural nodules are predictors of malignancy in mucusproducing. Histologic and Imaging Features of Mural Nodules in Mucinous Pancreatic Cysts.

Mural nodules are predictors of malignancy in mucusproducing. Histologic and Imaging Features of Mural Nodules in Mucinous Pancreatic Cysts. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2012;10:192 198 Histologic and Imaging Features of Mural Nodules in Mucinous Pancreatic Cysts NING ZHONG,*, LIZHI ZHANG, NAOKI TAKAHASHI, VLADISLAV SHALMIYEV,*

More information

MANAGEMENT RECOMMENDATIONS

MANAGEMENT RECOMMENDATIONS 1 MANAGEMENT RECOMMENDATIONS 1. Adrenal masses!!!!!!! page 2 2. Liver Masses!!!!!!! page 3 3. Obstetric US Soft Markers for Aneuploidy!! pages 4-6 4. Ovarian and Adnexal Cysts!!!!! pages 7-10 5. Pancreatic

More information

Predictors of Malignancy in Branch Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas

Predictors of Malignancy in Branch Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas ORIGINAL ARTICLE Predictors of Malignancy in Branch Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas Natsuko Kawada 1,3, Hiroyuki Uehara 2, Shigenori Nagata 1, Mutsumi Tsuchishima 3, Mikihiro

More information

Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds

Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds Imaging in jaundice and 2ww pathway Image protocol Staging Limitations Pancreatic cancer 1.2.4 Refer people using a suspected

More information

MRI Abdomen Protocol Pancreas/MRCP with Contrast

MRI Abdomen Protocol Pancreas/MRCP with Contrast MRI Abdomen Protocol Pancreas/MRCP with Contrast Reviewed By: Brett Mollard, MD; Anna Ellermeier, MD Last Reviewed: July 2018 Contact: (866) 761-4200 Standard uses: 1. Characterization of cystic and solid

More information

Neoplasias Quisticas del Páncreas

Neoplasias Quisticas del Páncreas SEAP -Aproximación Práctica a la Patología Gastrointestinal- Madrid, 26 de mayo, 2006 Neoplasias Quisticas del Páncreas Gregory Y. Lauwers, M.D. Director, Service Massachusetts General Hospital Harvard

More information

Validation of international consensus guideline 2012 for intraductal papillary mucinous neoplasm of pancreas

Validation of international consensus guideline 2012 for intraductal papillary mucinous neoplasm of pancreas ORIGINAL ARTICLE pissn 2288-6575 eissn 2288-6796 http://dx.doi.org/1.4174/astr.216.9.3.124 Annals of Surgical Treatment and Research Validation of international consensus guideline 212 for intraductal

More information

Evaluation of the 2015 AGA guidelines on pancreatic cystic neoplasms in a large surgically confirmed multicenter cohort

Evaluation of the 2015 AGA guidelines on pancreatic cystic neoplasms in a large surgically confirmed multicenter cohort Washington University School of Medicine Digital Commons@Becker Open Access Publications 2017 Evaluation of the 2015 AGA guidelines on pancreatic cystic neoplasms in a large surgically confirmed multicenter

More information

Research Article The Changing Spectrum of Surgically Treated Cystic Neoplasms of the Pancreas

Research Article The Changing Spectrum of Surgically Treated Cystic Neoplasms of the Pancreas HPB Surgery Volume 2015, Article ID 791704, 7 pages http://dx.doi.org/10.1155/2015/791704 Research Article The Changing Spectrum of Surgically Treated Cystic Neoplasms of the Pancreas Jennifer K. Plichta,

More information

The Use of Pancreatoscopy in the Diagnosis of Intraductal Papillary Mucinous Tumor Lesions of the Pancreas

The Use of Pancreatoscopy in the Diagnosis of Intraductal Papillary Mucinous Tumor Lesions of the Pancreas CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:S53 S57 The Use of Pancreatoscopy in the Diagnosis of Intraductal Papillary Mucinous Tumor Lesions of the Pancreas KENJIRO YASUDA, MUNEHIRO SAKATA, MOOSE

More information

American Gastroenterological Association Institute Guidelines for Management of Asymptomatic Neoplastic Pancreatic Cysts

American Gastroenterological Association Institute Guidelines for Management of Asymptomatic Neoplastic Pancreatic Cysts 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 American Gastroenterological Association Institute Guidelines for Management of Asymptomatic Neoplastic Pancreatic Cysts Santhi Swaroop Vege, 1 Barry Ziring, 2 Rajeev

More information

MRI features of serous oligocystic adenoma of the pancreas: differentiation from mucinous cystic neoplasm of the pancreas

MRI features of serous oligocystic adenoma of the pancreas: differentiation from mucinous cystic neoplasm of the pancreas The British Journal of Radiology, 85 (2012), 571 576 MRI features of serous oligocystic adenoma of the pancreas: differentiation from mucinous cystic neoplasm of the pancreas 1,2 J H LEE, MD, 1 J K KIM,

More information

pissn: , eissn: Yonsei Med J 53(1): , 2012

pissn: , eissn: Yonsei Med J 53(1): , 2012 Original Article http://dx.doi.org/10.3349/ymj.2012.53.1.106 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 53(1):106-110, 2012 Comparison of Efficacy of Enucleation and Pancreaticoduodenectomy for Small

More information

Surgical Management of Pancreatic Cancer

Surgical Management of Pancreatic Cancer I Congresso de Oncologia D Or July 5-6, 2013 Surgical Management of Pancreatic Cancer Michael A. Choti, MD, MBA, FACS Department of Surgery Johns Hopkins University School of Medicine, Baltimore, MD Estimated

More information

Comparison of multidetector-row computed tomography findings of IgG4-related sclerosing cholangitis and cholangiocarcinoma

Comparison of multidetector-row computed tomography findings of IgG4-related sclerosing cholangitis and cholangiocarcinoma Comparison of multidetector-row computed tomography findings of IgG4-related sclerosing cholangitis and cholangiocarcinoma Poster No.: C-0245 Congress: ECR 2014 Type: Scientific Exhibit Authors: M. Yata,

More information

The Pancreas. Basic Anatomy. Endocrine pancreas. Exocrine pancreas. Pancreas vasculature. Islets of Langerhans. Acinar cells Ductal System

The Pancreas. Basic Anatomy. Endocrine pancreas. Exocrine pancreas. Pancreas vasculature. Islets of Langerhans. Acinar cells Ductal System SGNA: Back to Basics Rogelio G. Silva, MD Assistant Clinical Professor of Medicine University of Illinois at Chicago Department of Medicine Division of Gastroenterology Advocate Christ Medical Center GI

More information

Genetics of Pancreatic Cancer. October 6, If you experience technical difficulty during the presentation:

Genetics of Pancreatic Cancer. October 6, If you experience technical difficulty during the presentation: Genetics of Pancreatic Cancer October 6, 2016 If you experience technical difficulty during the presentation: Contact WebEx Technical Support directly at: US Toll Free: 1-866-229-3239 Toll Only: 1-408-435-7088

More information

Pancreatobiliary Frozen Section Nightmares

Pancreatobiliary Frozen Section Nightmares Pancreatobiliary Frozen Section Nightmares Aatur D. Singhi, MD PhD Assistant Professor University of Pittsburgh Medical Center Department of Pathology singhiad@upmc.edu Objectives Briefly give an overview

More information

Surgical management and results for cystic neoplasms of pancreas

Surgical management and results for cystic neoplasms of pancreas Korean J Hepatobiliary Pancreat Surg 2013;17:118-125 Original Article Surgical management and results for cystic neoplasms of pancreas Kyung Won Han 1, Ryun Ha 1, Kun Kuk Kim 1, Jung Nam Lee 1, Yeon Suk

More information

Cystic lesions of the pancreas

Cystic lesions of the pancreas REVIEW ARTICLE Annals of Gastroenterology (2016) 29, 155-161 Cystic lesions of the pancreas Ioannis Karoumpalis a, Dimitrios K. Christodoulou b General Hospital of Athens G. Gennimatas, Athens; University

More information

Patient with incidental pancreatic cyst

Patient with incidental pancreatic cyst Clinical problem Diego Aponte M, MD 1 1 Internal Medicine Gastroenterology Specialist. Gastroenterology Academic Coordinator for Graduate Level. Fundación Sanitas. Bogotá, Colombia.... Received: 07-09-10

More information

X-Ray Corner. Imaging Approach to Cystic Liver Lesions. Pantongrag-Brown L. Solitary cystic liver lesions. Hepatic simple cyst (Figure 1)

X-Ray Corner. Imaging Approach to Cystic Liver Lesions. Pantongrag-Brown L. Solitary cystic liver lesions. Hepatic simple cyst (Figure 1) THAI J 136 Imaging Approach to Cystic Liver Lesions GASTROENTEROL 2013 X-Ray Corner Imaging Approach to Cystic Liver Lesions Pantongrag-Brown L Cystic liver lesions are common findings in daily practice

More information

Nonsurgical Management of Asymptomatic Incidental Pancreatic Cysts

Nonsurgical Management of Asymptomatic Incidental Pancreatic Cysts CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2007;5:813 817 Nonsurgical Management of Asymptomatic Incidental Pancreatic Cysts MAOR LAHAV, YAKOV MAOR, BENJAMIN AVIDAN, BEN NOVIS, and SIMON BAR MEIR Department

More information

Cystic Lesions of the Pancreas

Cystic Lesions of the Pancreas Residents Section Pattern of the Month w668 04.29.11 Khan et al. Residents Section Pattern of the Month Residents inradiology tif Khan 1 Faisal Khosa Ronald L. Eisenberg Khan, Khosa F, Eisenberg RL Keywords:

More information

Pancreatic Cystic Lesions 원자력병원

Pancreatic Cystic Lesions 원자력병원 Pancreatic Cystic Lesions 원자력병원 박선 후 Lines of cellular differentiation Ductal Acinar Undetermined Ductal adenocarcinoma Serous/ mucinous tumor Intraductal papillary mucinous neoplasm Acinar cell carcinoma

More information

REVIEW ARTICLE INTRODUCTION SURGICAL MANAGEMENT ABSTRACT

REVIEW ARTICLE INTRODUCTION SURGICAL MANAGEMENT ABSTRACT JOP. J Pancreas (Online) 2015 Sep 08; 16(5):417-424. REVIEW ARTICLE Fate of the Pancreatic Remnant Following Curative Intent Surgical Resection for Intraductal Pancreatic Mucinous Neoplasms: An Overview

More information

Cystic Schwannoma of the Pancreas: A Case Report 1

Cystic Schwannoma of the Pancreas: A Case Report 1 Cystic Schwannoma of the Pancreas: A Case Report 1 Hee Jung Kim, M.D., Won Jae Lee, M.D., Sung Mok Kim, M.D., Kee-Taek Jang, M.D. 2 A pancreatic schwannoma is an extremely rare pancreatic neoplasm. This

More information

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management. Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician

More information

Every now and then a disease emerges that manages to

Every now and then a disease emerges that manages to Mini-Reviews and Perspectives Intraductal Papillary Mucinous Neoplasms of the Pancreas CARLOS FERNÁNDEZ DEL CASTILLO* and N. VOLKAN ADSAY *Pancreas and Biliary Surgery Program, Massachusetts General Hospital,

More information

Introduction E389. Background and study aims Guidelines for management

Introduction E389. Background and study aims Guidelines for management Impact of endoscopic ultrasound on diagnosis and management of presumed mucinous neoplasms when done for pancreatic cyst morphology change on non-invasive surveillance imaging Authors Kamraan Madhani 1,

More information

Solid Pancreatic Tumors with Unilocular Cyst-Like Appearance on CT: Differentiation from Unilocular Cystic Tumors Using CT

Solid Pancreatic Tumors with Unilocular Cyst-Like Appearance on CT: Differentiation from Unilocular Cystic Tumors Using CT Original Article Gastrointestinal Imaging http://dx.doi.org/10.3348/kjr.2014.15.6.704 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2014;15(6):704-711 Solid Pancreatic Tumors with Unilocular Cyst-Like

More information

Case Report A Case Report of Intraductal Papillary-Mucinous Neoplasm of the Pancreas Showing Morphologic Transformation during Followup Periods

Case Report A Case Report of Intraductal Papillary-Mucinous Neoplasm of the Pancreas Showing Morphologic Transformation during Followup Periods Oncology Volume 2009, Article ID 373465, 6 pages doi:10.1155/2009/373465 Case Report A Case Report of Intraductal Papillary-Mucinous Neoplasm of the Pancreas Showing Morphologic Transformation during Followup

More information

Unusual Pancreatic Neoplasms RTC 2/11/2011

Unusual Pancreatic Neoplasms RTC 2/11/2011 Unusual Pancreatic Neoplasms RTC 2/11/2011 Objectives Intraductal Papillary Mucinous Neoplasm (IPMN) Mucinous Cystic Neoplasm (MCN) Islet Cell Tumors Insulinoma Glucagonoma VIPoma Somatostatinoma Gastrinoma

More information

Pancreatic Cysts - Part 2

Pancreatic Cysts - Part 2 REVIEW Pancreatic Cysts - Part 2 Should We Be Less Cyst Centric? Anne Marie Lennon, MD, PhD and Marcia Irene Canto, MD, MHS Abstract: The management of pancreatic cysts is a common problem faced by physicians

More information

Chromophobe Renal Cell Carcinoma: Multiphase MDCT Enhancement Patterns and Morphologic Features

Chromophobe Renal Cell Carcinoma: Multiphase MDCT Enhancement Patterns and Morphologic Features Genitourinary Imaging Original Research Raman et al. Enhancement Patterns and Morphologic Features of Chromophobe Renal Cell Carcinoma Genitourinary Imaging Original Research Siva P. Raman 1 Pamela T.

More information

7th Annual Symposium on Gastrointestinal Cancers " St. Louis, Mo, 9/20/08

7th Annual Symposium on Gastrointestinal Cancers  St. Louis, Mo, 9/20/08 Molecular markers to aid in early diagnosis of pancreatic cancer Michael Goggins, MD Professor of Pathology, Medicine and Oncology Johns Hopkins Medical Institutions, Baltimore, MD 7th Annual Symposium

More information

Case 1. Case 1: EUS Report 5/1/2017. Interesting Cases of Pancreatic Masses

Case 1. Case 1: EUS Report 5/1/2017. Interesting Cases of Pancreatic Masses Interesting Cases of Pancreatic Masses Martha Bishop Pitman, MD Professor of Pathology Harvard Medical School Director of Cytopathology Massachusetts General Hospital Boston, MA MASSACHUSETTS GENERAL PHYSICIANS

More information

Multiple Primary Quiz

Multiple Primary Quiz Multiple Primary Quiz Case 1 A 72 year old man was found to have a 12 mm solid lesion in the pancreatic tail by computed tomography carried out during a routine follow up study of this patient with adult

More information

Current Recommendations for Surveillance and Surgery of Intraductal Papillary Mucinous Neoplasms May Overlook Some Patients with Cancer

Current Recommendations for Surveillance and Surgery of Intraductal Papillary Mucinous Neoplasms May Overlook Some Patients with Cancer J Gastrointest Surg (2015) 19:258 265 DOI 10.1007/s11605-014-2693-z ORIGINAL ARTICLE Current Recommendations for Surveillance and Surgery of Intraductal Papillary Mucinous Neoplasms May Overlook Some Patients

More information

Pancreatic Adenocarcinoma: Everything You Need to Know From Cross-Sectional Imaging to Treatment

Pancreatic Adenocarcinoma: Everything You Need to Know From Cross-Sectional Imaging to Treatment Pancreatic Adenocarcinoma: Everything You Need to Know From Cross-Sectional Imaging to Treatment Andrew W. Bowman, MD PhD Assistant Professor of Radiology Mayo Clinic Florida SCBT-MR Annual Meeting Nashville,

More information